Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
2008
Location
Pont Saint Martin, Italy
Number of Employees
10
Focus
Applications and services for biopharmaceutical drug development,
including
data
retrieval
and
annotation, text mining, network
analysis
Company Profile
BioDigitalValley is a company dedicated to invent, develop and
commercialize new solutions and services in the bioinformatics field. It
is part of the R.G.I. group, a software house participated by the equity
fund 21 Investimenti (Benetton).
The Companys lead product, ProteinQuest, was released early in
2012. ProteinQuest is a new platform for biomedical data retrieval and
analysis, useful for pharmaceutical discovery and as well as business
intelligence in the biomedical sector. First customers include academic
research institutions, discovery groups in pharmaceutical companies
and licensing officers from the same.
The second product, iMOLE, is a specialized platform designed to
store, analyze and retrieve experimental images from both research
labs and scientific literature. Currently, iMOLE has been customized for
an academic research group working on 2D-gel electrophoresis data.
Discovery and Innovation Capabilities
The Companys discovery capability, mainly focused in the field of
informatics applications for research in the pharmaceutical industry,
draws on years of experience and the world class standing of its
informatics and programming expert, as well as on several academic
collaborations at the border between several hot topics in informatics
research (cloud and grid applications, semantic indexing) and
molecular biology (system biology).
Products
ProteinQuest
iMOLE
Contact Details
Biodigitalvalley Srl
Via Carlo Viola, 78
IT-11026 Pont Saint Martin (AO)
Italy
Phone: +39 (0)125 344249
Fax: +39 (0)125 1865225
E-Mail: info@biodigitalvalley.com
Web: www.biodigitalvalley.com
Collaborations
In the frame of the IMAGE project, Biodigitalvalley headed a
collaboration involving the Informatics Dept. of the University of Milano,
aimed to the development of new tools for the retrieval and reutilization
of proteomic images from the scientific literature (project value: about
900 k euro).
After that, Biodigitalvalley collaborated with the Neurology dept. of the
Valle dAosta hospital and with the University of Insubria on a pilot
study using Biodigitalvalley technology to find and validate molecular
biomarkers in Parkinsons disease (ParIS project, about 1.5 M. euro).
Currently, Biodigitalvalley is starting a collaboration including the
Istituto Mario Boella (TO) and the Italian Interuniversitary Consortium
for Informatic (CINI) aiming to develop cloud applications and an open
source platform for the pharmaceutical discovery.
The Company has also been recently contacted by the University of
Barcelona and by the French CNRS to explore possible collaborations
in the same sector, with the goal of setting up a EU-FP7 project
proposal.
Business Development
Biodigitalvalley welcomes enquiries from potential partners interested
in finding out more about its products and services.
Funds Raised
EURO 3 M
Current Investors
R.G.I. group (Milano, Italy)
Research collaborations
University of Insubria: since 2010
CINI: since 2012
Istituto M.Boella: since 2012
IMAGE: 2009-2010, funded by the
VdA Regional Governement; worth
EURO 1000 k
PARIS: 2010-2012, funded by the
VdA Regional Governement; worth
EURO 1500 k
Management
Paolo Benini - President
Enrico Bucci, PhD CEO
Dario Bonino - CTO
Contact Details
Biodigitalvalley Srl
Via Carlo Viola, 78
IT-11026 Pont Saint Martin (AO)
Italy
Phone: +39 (0)125 344249
Fax: +39 (0)125 1865225
E-Mail: info@biodigitalvalley.com
Web: www.biodigitalvalley.com